Research Article
Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker
Table 1
Clinical characteristics of the patients.
| | Item | Patients with lung cancer | Patients without lung cancer | value |
| | Number () | 89 | 84 | — | | Sexuality (male/female) | 67/22 | 50/33 | — | | Age (year) | | | | | (°C) | 36.75 (36.50-37.40) | 36.87 (36.50-37.05) | | | Pause (per/min) | 82 (76-87.5) | 80 (78-88) | | | Respiration (per/min) | 20 (19-21) | 20 (20-20) | | | SBP (mmHg) | 120 (110-132) | 120 (110-130) | | | DBP (mmHg) | 78 (70-80) | 73 (70-80) | | | WBC count (×109/L) | 6.75 (5.79-8.17) | 7.15 (4.76-8.76) | | | Neutrophil count (×109/L) | 4.74 (3.73-6.03) | 5.04 (3.46-6.78) | | | Neutrophil percentage (%) | 72.36 (64.7-78.6) | 73.11 (67.54-80.20) | | | Monocyte count (×109/L) | 0.42 (0.30-0.55) | 0.35 (0.24-0.52) | | | Monocyte percentage (%) | 5.75 (4.47-7.20) | 5.10 (4.20-6.60) | | | Pulmonary complications | — | — | — | | COPD () | 9 | 8 | — | | Bronchiectasis () | 2 | 2 | — | | Interstitial disease () | 3 | 0 | — | | Pleural effusion () | 22 | 12 | — |
|
|
